Police said she pleaded guilty to one count of attempted first-degree assault with a firearm.Judicial Branch records show ...
Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall ...
By Michael Erman and Sriparna Roy (Reuters) -Bristol Myers Squibb on Thursday said its 2025 revenue would fall more sharply ...
Ed: As usual, a disappointing lack of ambition from the senior management to push hard for promotion. They blame the transfer ...
The drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a ...
(Reuters) -Bristol Myers Squibb on Thursday posted better-than-expected fourth-quarter earnings, but said its 2025 revenue ...
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to explain why he's selling Bristol Myers so ...
Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.
The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...
Recent health news includes Bristol Myers' projected revenue dip due to generic competition and cost cuts, Trump's tariffs ...
BMS is not the only U.S. pharma giant making massive cuts. Last year, Pfizer revealed a similar plan to reduce $1.5 billion ...
The University of Bristol Student’s Union has passed a motion to make the entire university plant-based. The Annual Members ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results